biomarker

You have access
Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma
TAKASHI KATO, TARO OSHIKIRI, HIRONOBU GOTO, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA and YOSHIHIRO KAKEJI

Anticancer Research May 2022, 42 (5) 2775-2782; DOI: https://doi.org/10.21873/anticanres.15757
Open Access
sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma
VIVIAN BARAK, INA KALICKMAN and JACOB PE’ER

Anticancer Research March 2022, 42 (3) 1447-1453; DOI: https://doi.org/10.21873/anticanres.15615
You have access
The Gut Microbiome as a Biomarker of Cancer Progression Among Female Never-smokers With Lung Adenocarcinoma
TAKEHIRO OTOSHI, TATSUYA NAGANO, JONGUK PARK, KOJI HOSOMI, TOMOYA YAMASHITA, MOTOKO TACHIHARA, TOKIKO TABATA, REINA SEKIYA, YUGO TANAKA, KAZUYUKI KOBAYASHI, KENJI MIZUGUCHI, TOMOO ITOH, YOSHIMASA MANIWA, JUN KUNISAWA and YOSHIHIRO NISHIMURA

Anticancer Research March 2022, 42 (3) 1589-1598; DOI: https://doi.org/10.21873/anticanres.15633
You have access
CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer
TOSHIAKI HAGIWARA, KIICHI SUGIMOTO, HIROTAKA MOMOSE, TAKAHIRO IRIE, KUMPEI HONJO, YU OKAZAWA, MASAYA KAWAI, SHINGO KAWANO, SHINYA MUNAKATA, MAKOTO TAKAHASHI, YUTAKA KOJIMA, NOBUKO SERIZAWA, AKIHITO NAGAHARA, ROBERT M. HOFFMAN, MALCOLM V. BROCK and KAZUHIRO SAKAMOTO

Anticancer Research February 2022, 42 (2) 697-707; DOI: https://doi.org/10.21873/anticanres.15528
You have access
Clinical Impact of CYFRA 21-1 a Marker for Treatment Failure in Patients With Oropharyngeal Cancer Treated by Radio(chemo)therapy
STEFAN A. RUDHART, PHILIPP LANGEN, KRUTHIKA THANGAVELU, FRANCESCA GEHRT, PETAR STANKOVIC, THOMAS WILHELM, BORIS A. STUCK and STEPHAN HOCH

Anticancer Research January 2022, 42 (1) 137-146; DOI: https://doi.org/10.21873/anticanres.15467
You have access
MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer
BETTINA SAVARESE-BRENNER, MARLENE HEUGL, BARBARA RATH, CONRADIN SCHWEIZER, EVA OBERMAYR, SANDRA STICKLER and GERHARD HAMILTON

Anticancer Research January 2022, 42 (1) 429-439; DOI: https://doi.org/10.21873/anticanres.15501
You have access
Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8⁺ T Cells: A Study Based on The Cancer Genome Atlas (TCGA)
SATORU YONEKURA

Anticancer Research January 2022, 42 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.15509
You have access
DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer
JIANCHUN WU, KATE JILLIAN GALVAN, RYAN D. BOGARD, CARYN E. PETERSON, ARDAMAN SHERGILL and DAVID L. CROWE

Anticancer Research November 2021, 41 (11) 5393-5403; DOI: https://doi.org/10.21873/anticanres.15351
You have access
Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
YUJI NOJIMA, KATSUHIKO SHIMIZU, SHINSUKE SAISHO, AI MAEDA, TAKESHI KUROSAKI, KOJI KUROSE, TORU OGA, MIKIO OKA and MASAO NAKATA

Anticancer Research November 2021, 41 (11) 5469-5475; DOI: https://doi.org/10.21873/anticanres.15359
You have access
Analysis of Mesencephalic Astrocyte-derived Neurotrophic Factor in Multiple Myeloma
AMANDINE DERNONCOURT, CHLOE SAUZAY, JEAN SCHMIDT, CHRISTOPHE LOUANDRE, CATHY GOMILA, PIERRE DUHAUT, YVES-EDOUARD HERPE, ZUZANA SAIDAK, ANTOINE GALMICHE and VALERY SALLE

Anticancer Research September 2021, 41 (9) 4305-4312; DOI: https://doi.org/10.21873/anticanres.15235

Main menu

User menu

Search

biomarker

Pages